Bioventix (LON:BVXP) Stock Passes Below 200-Day Moving Average – Should You Sell?

Bioventix PLC (LON:BVXP) shares passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 2,210.20 and traded as low as GBX 1,850. Bioventix shares last traded at GBX 1,855, with a volume of 21,306 shares changing hands.

Bioventix Price Performance

The firm’s fifty day moving average is GBX 1,827.19 and its 200 day moving average is GBX 2,203.95. The firm has a market capitalization of £97.19 million, a price-to-earnings ratio of 12.98 and a beta of 0.35.

Insider Buying and Selling at Bioventix

In other news, insider Peter John Harrison bought 875 shares of the stock in a transaction on Tuesday, November 4th. The shares were purchased at an average price of GBX 2,220 per share, for a total transaction of £19,425. Also, insider Bruce Hiscock bought 150 shares of the company’s stock in a transaction on Tuesday, November 25th. The stock was purchased at an average cost of GBX 2,071 per share, for a total transaction of £3,106.50. Insiders own 6.16% of the company’s stock.

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.